Tyra Biosciences (TYRA) Shares Issued (2020 - 2026)
Quarterly Shares Issued changed N/A to $147.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $146.2 million through Mar 2026, changed N/A year-over-year, with the annual reading at $181.2 million for FY2021, N/A changed from the prior year.
Tyra Biosciences filings provide 3 years of Shares Issued readings, the most recent being $147.9 million for Q1 2026.
- Shares Issued hit $147.9 million in Q1 2026 for Tyra Biosciences, up from -$1.5 million in the prior quarter.
- Across five years, Shares Issued topped out at $147.9 million in Q1 2026 and bottomed at $147.9 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 163.10 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 147.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147.85 Mn |
| Mar 31, 2026 | 147.85 Mn |
| Dec 31, 2021 | -1.51 Mn |
| Dec 31, 2021 | -1.51 Mn |
| Dec 31, 2020 | -140,000.00 |
| Dec 31, 2020 | -140,000.00 |